Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05053152 |
| Title | Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer (NRG PROMETHEAN) |
| Acronym | NRG PROMETHEAN |
| Recruitment | Recruiting |
| Gender | male |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | NRG Oncology |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | CAN |